Pharma giant Bayer scouts Israeli startup scene in search of competitive edge
Hugo Hagen, the managing director & country division head of Bayer, Israel. (Courtesy: Danit Nitzan/Bayer) If the coronavirus pandemic has proved something to global pharmaceutical giants, it is that they need to tap into the power of younger, nimbler startups and the latest technologies to be able to stay at the top of their game and ahead of competition. Of the three coronavirus vaccines being widely distributed in the West, one was the result of a partnership between a blue chip pharma firm and a biotech startup — Pfizer-BioNTech; one was the result of a collaboration between another mas...
Source: timesofisrael.com